There has recently been a dramatic renewal of interest in hadron spectroscopy and charm physics. This renaissance has been driven in part by the discovery of a plethora of charmonium-like XYZ states at BESIII and B factories, and the observation of an intriguing proton-antiproton threshold enhancement and the possibly related X(1835) meson state at BESIII, as well as the threshold measurements of charm mesons and charm baryons.
We present a detailed survey of the important topics in tau-charm physics and hadron physics that can be further explored at BESIII during the remaining operation period of BEPCII. This survey will help in the optimization of the data-taking plan over the coming years, and provides physics motivation for the possible upgrade of BEPCII to higher luminosity.
The Born cross section for the process e þ e − → pp is measured using the initial state radiation technique with an undetected photon. This analysis is based on datasets corresponding to an integrated luminosity of 7.5 fb −1 , collected with the BESIII detector at the BEPCII collider at center of mass energies between 3.773 and 4.600 GeV. The Born cross section for the process e þ e − → pp and the proton effective form factor are determined in the pp invariant mass range between 2.0 and 3.8 GeV=c 2 divided into 30 intervals. The proton form factor ratio (jG E j=jG M j) is measured in 3 intervals of the pp invariant mass between 2.0 and 3.0 GeV=c 2 .
We study the e þ e − → γωJ=ψ process using 11.6 fb −1 e þ e − annihilation data taken at center-of-mass energies from ffiffi ffi s p ¼ 4.008 GeV to 4.600 GeV with the BESIII detector at the BEPCII storage ring. The
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.